We studied the commercialization strategies of young biotechnology companies in the United States building on previous studies by assuming that commercialization also includes intermediate forms like hierarchical or bilateral cooperation. Our hypotheses are derived from the Resource-Based View,...

In this paper, we examine a markets’ readiness for potential disruptive innovations based on past and current conditions. For this purpose, we developed a theoretical framework to evaluate the “disruptive susceptibility” of value networks. Using the construct of disruptive susceptibility,...